Ulbright Thomas M
Department of Pathology & Laboratory Medicine, Clarian Health Partners and Indiana University School of Medicine, Indianapolis, IN 46202-5280, USA.
Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310.
Gonadal germ cell tumors continue to be the cause of diverse, diagnostically challenging issues for the pathologist, and their correct resolution often has major important therapeutic and prognostic implications. They are academically interesting because of the biological diversity exhibited in the two gonads and variation in frequency of certain neoplasms. The most dramatic examples of the latter are the frequency of dermoid cyst in the ovary compared to the testis and the reverse pertaining to embryonal carcinoma. Within the teratoma group, there is strong evidence that ovarian and prepubertal testicular teratomas are derived from benign germ cells, a pathogenesis that likely applies also to the rare dermoid cysts and uncommon epidermoid cysts of the testis. In contrast, postpubertal testicular teratomas derive from malignant germ cells, specifically representing differentiation within a preexistent nonteratomatous cancer. As expected, given the foregoing, teratomas in boys are clinically benign, whereas in postpubertal males they are malignant, independent of their degree of immaturity. On the other hand, immaturity is an important finding in ovarian teratomas, irrespective of age, although its significance in children has recently been challenged. It is usually recognized on the basis of embryonic-appearing neuroepithelium, which shows mitotic activity and apoptosis in contrast to differentiated neuroepithelial tissues, which may occur in mature ovarian teratomas. Rarely it is based on the presence of cellular, mitotically active glial tissue. Fetal-type tissues alone are not sufficient for a diagnosis of immature teratoma. Further differences between the teratomatous tumors in the two gonads are the relative frequency of monodermal teratomas in the ovary in contrast to the testis, where only one subset, carcinoids, is seen with any frequency. When uncommon somatic-type malignancies (usually squamous cell carcinoma) occur in mature cystic teratomas of the ovary, this is a de novo form of malignant transformation; similar tumors in the testis, a very rare event, represent overgrowth of teratomatous elements that originated from malignant, nonteratomatous germ cell tumors and, therefore, had previously undergone malignant transformation. Germinomas may have several unusual features in each gonad; these include microcystic arrangements that suggest yolk sac tumor, tubular patterns that mimic Sertoli cell tumor, apparent increased cytological atypia that causes concern for embryonal carcinoma, and prominent syncytiotrophoblast giant cells that suggest choriocarcinoma. Awareness of these variants, good technical preparations, the retained typical cytological features of germinoma cells, and the judicious use of tailored panels of immunohistochemical stains resolve these dilemmas in virtually all instances. Two aspects of germinomas are unique to the testis. Firstly, intertubular growth of small seminomas may cause them to be overlooked. Secondly, the distinctive spermatocytic seminoma occurs only in the testis. A newly recognized aspect of this tumor is the propensity for some to be relatively monomorphic, making them apt to be mistaken for usual seminoma or embryonal carcinoma, although the characteristic polymorphic appearance in some foci, absence of intratubular germ cell neoplasia, unclassified type, and immunohistochemical stains should prevent this error. Cytoplasmic membrane immunoreactivity for placental alkaline phosphatase and CD117, with usual negativity for AE1/AE3 cytokeratins, is helpful in the diagnosis of germinoma. The recently described marker, OCT3/4, a nuclear transcription factor, is especially helpful in the differential of germinoma and embryonal carcinoma with other neoplasms. Yolk sac tumor continues to be confused occasionally with clear cell carcinoma of the ovary. Glandular ('endometrioid-like') yolk sac tumors mimic endometrioid carcinomas; predominant or pure hepatoid yolk sac tumors cause concern for metastatic hepatocellular carcinoma or, in the ovary, primary hepatoid carcinoma, and solid patterns, especially in limited samplings, may be misinterpreted as germinoma. The usually younger age of patients with yolk sac tumors helps with the differential considerations with the nongerm cell tumors, as do other clinical and microscopic features and selected immunohistochemical stains. Choriocarcinoma is rare in both gonads, and those in the ovary must be distinguished from metastatic tumors of placental origin. Syncytiotrophoblast cells alone, admixed with other forms of germ cell tumor, still are confused with choriocarcinoma, but this phenomenon, which is much more frequent than choriocarcinoma, lacks the plexiform arrangement of different trophoblast cell types that typifies the latter. Mixed germ cell tumors (which may show almost any combination of components) are common in the testis but rare in the ovary. A separately categorized, rare form of mixed germ cell tumor seen in both gonads is the polyembryoma. It is perhaps the most photogenic of all gonadal germ cell tumors and is also intriguing because of its distinctive, organized arrangement of yolk sac tumor and embryonal carcinoma elements and recapitulation of very early embryonic development, even to the extent of having in its fundamental unit, the embryoid body, a miniature yolk sac, and amniotic cavity. These tumors, which are constituted by innumerable embryoid bodies, almost always contain teratomatous glands in minor amounts, and one way of viewing the polyembryoma is to consider it the most immature form of teratoma. Embryoid bodies are also common as a minor component of many mixed germ cell tumors, particularly in the testis, and the diffuse embryoma is another variant that has a particular arrangement of yolk sac tumor and embryonal carcinoma elements. Regression of gonadal germ cell tumors is a phenomenon restricted to the testis, for unknown reasons. These so-called 'burnt-out' germ cell tumors can be recognized by a distinctive constellation of findings, including sometimes minor foci of residual recognizable germ cell neoplasia, a well-defined zone of scarring (often having residual ghost tubules), associated lymphoplasmacytic infiltrate, intratubular calcification and, in about 50%, of in situ germ cell neoplasia.
性腺生殖细胞肿瘤仍然是病理学家面临的诊断难题的多样化原因,其正确诊断往往对治疗和预后具有重大意义。由于两个性腺表现出的生物学多样性以及某些肿瘤发生率的差异,它们在学术上很有趣。后者最显著的例子是卵巢皮样囊肿与睾丸皮样囊肿的发生率差异,以及胚胎癌的情况则相反。在畸胎瘤组中,有充分证据表明卵巢和青春期前睾丸畸胎瘤源自良性生殖细胞,这种发病机制可能也适用于罕见的睾丸皮样囊肿和不常见的表皮样囊肿。相比之下,青春期后睾丸畸胎瘤源自恶性生殖细胞,具体表现为在先前存在的非畸胎瘤性癌症内的分化。不出所料,鉴于上述情况,男孩的畸胎瘤在临床上是良性的,而在青春期后男性中则是恶性的,与它们的不成熟程度无关。另一方面,不成熟是卵巢畸胎瘤的一个重要发现,无论年龄如何,尽管其在儿童中的意义最近受到了质疑。它通常基于出现胚胎样神经上皮来识别,与成熟卵巢畸胎瘤中可能出现的分化神经上皮组织相比,胚胎样神经上皮显示有丝分裂活性和凋亡。很少情况下,它是基于存在细胞性、有丝分裂活性的神经胶质组织。仅胎儿型组织不足以诊断不成熟畸胎瘤。两个性腺中的畸胎瘤性肿瘤的进一步差异在于卵巢中单一胚层畸胎瘤的相对频率与睾丸中单一胚层畸胎瘤的相对频率不同,在睾丸中,只有类癌这一亚型有一定频率出现。当卵巢成熟囊性畸胎瘤中出现罕见的体细胞型恶性肿瘤(通常是鳞状细胞癌)时,这是一种恶性转化的新形式;睾丸中类似的肿瘤是一种非常罕见的情况,代表源自恶性非畸胎瘤性生殖细胞肿瘤的畸胎瘤成分过度生长,因此先前已经发生了恶性转化。生殖细胞瘤在每个性腺中可能有几个不寻常的特征;这些特征包括提示卵黄囊瘤的微囊性排列、模仿支持细胞瘤的管状模式、导致对胚胎癌担忧的明显细胞学异型性增加以及提示绒毛膜癌的显著合体滋养层巨细胞。认识到这些变异、良好的技术准备、生殖细胞瘤细胞保留的典型细胞学特征以及明智地使用定制的免疫组织化学染色组合,几乎在所有情况下都能解决这些难题。生殖细胞瘤在睾丸中有两个独特的方面。首先,小精原细胞瘤的小管间生长可能导致它们被忽视。其次,独特的精母细胞性精原细胞瘤仅发生在睾丸中。这种肿瘤新认识到的一个方面是,有些肿瘤倾向于相对单一形态,容易被误认为是普通精原细胞瘤或胚胎癌,尽管某些病灶中特征性的多形性外观、不存在小管内生殖细胞肿瘤未分类类型以及免疫组织化学染色应可防止这种错误。胎盘碱性磷酸酶和CD117的细胞质膜免疫反应性,以及AE1/AE3细胞角蛋白通常为阴性,有助于生殖细胞瘤的诊断。最近描述的标记物OCT3/4,一种核转录因子,在生殖细胞瘤与胚胎癌及其他肿瘤的鉴别中特别有帮助。卵黄囊瘤偶尔仍会与卵巢透明细胞癌混淆。腺管状(“子宫内膜样”)卵黄囊瘤模仿子宫内膜样癌;主要为或纯的肝样卵黄囊瘤会让人担心是转移性肝细胞癌,或者在卵巢中是原发性肝样癌,而实性模式,尤其是在有限取材时,可能会被误诊为生殖细胞瘤。卵黄囊瘤患者通常较年轻,这有助于与非生殖细胞肿瘤进行鉴别,其他临床和显微镜特征以及选择特定的免疫组织化学染色也有助于鉴别。绒毛膜癌在两个性腺中都很罕见,卵巢中的绒毛膜癌必须与胎盘来源的转移性肿瘤区分开来。单独的合体滋养层细胞,与其他形式的生殖细胞肿瘤混合,仍然会与绒毛膜癌混淆,但这种现象比绒毛膜癌更常见,缺乏典型的不同滋养层细胞类型的丛状排列。混合性生殖细胞肿瘤(可能显示几乎任何成分组合)在睾丸中很常见,但在卵巢中很少见。在两个性腺中都可见的一种单独分类的罕见混合性生殖细胞肿瘤形式是多胚瘤。它可能是所有性腺生殖细胞肿瘤中最上镜的,也很有趣,因为其独特的、有组织的卵黄囊瘤和胚胎癌成分排列以及对非常早期胚胎发育的重现,甚至在其基本单位胚体中就有微型卵黄囊和羊膜腔。这些由无数胚体组成的肿瘤几乎总是含有少量畸胎瘤性腺管,看待多胚瘤的一种方式是将其视为最不成熟的畸胎瘤形式。胚体在许多混合性生殖细胞肿瘤中也是常见的次要成分,特别是在睾丸中,弥漫性胚瘤是另一种具有卵黄囊瘤和胚胎癌成分特定排列的变体。性腺生殖细胞肿瘤的消退是一种仅限于睾丸的现象,但原因不明。这些所谓的“消退型”生殖细胞肿瘤可以通过一系列独特的发现来识别,包括有时残留的可识别生殖细胞肿瘤的微小病灶、明确的瘢痕形成区域(通常有残留的幽灵小管)、相关的淋巴浆细胞浸润、小管内钙化,约50%的病例中还有原位生殖细胞肿瘤。